Adding a radioisotope to the toolkit for saving lives

MU researchers study terbium-161 with the hope that one day it could be the next major radioisotope produced to treat cancer.

Carolyn Anderson, left, and graduate student Ejike Iweha discuss research on terbium-161 in the Anderson lab at the University of Missouri's Molecular Imaging and Theranostics Center.

Feb. 27, 2024

Ground-breaking innovation at Mizzou provides patients around the world with access to a lifesaving toolbox of vital pharmaceutical ingredients called radioisotopes produced at only one location in the United States — the University of Missouri Research Reactor (MURR).

Read More